(Q109919407)
Statements
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (English)
0 references
17 December 2020
0 references
27
0 references
2
0 references
279-288
0 references